Natco Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 25	Sep ' 24	Sep ' 23	Sep ' 22	Mar ' 22

Sales

2,457.00

2,529.50

1,978.80

1,156.80

1,043.60

Operating profit

1,092.20

1,553.70

946.00

449.50

50.00

Interest

14.30

7.40

6.20

4.40

8.30

Gross profit

1,230.80

1,637.50

979.10

494.50

83.70

EPS (Rs)

53.91

72.48

42.77

18.94

0.56

Other income

152.90

91.20

39.30

49.40

42.00

Stock adjustment

-45.80

-14.10

39.50

-

62.80

Raw material

355.50

294.50

302.70

196.20

293.70

Power and fuel

-

-

-

-

-

Employee expenses

322.10

253.00

226.00

236.50

210.20

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

733.00

442.40

464.60

274.60

426.90

Provisions made

-

-

-

-

-

Depreciation

101.90

82.60

79.90

75.20

71.10

Taxation

163.90

257.50

133.70

73.60

2.30

Net profit / loss

965.00

1,297.40

765.50

345.70

10.30

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

35.80

35.80

35.80

36.50

36.50

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

44.45

61.42

47.81

38.86

4.79

GPM (%)

47.16

62.48

48.52

41.00

7.71

NPM (%)

36.97

49.51

37.93

28.66

0.95